{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T20:05:29Z","timestamp":1760299529401,"version":"3.41.0"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100005285","name":"FAPEG","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005285","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"CAPES","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"CNPq","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.ejphar.2017.02.031","type":"journal-article","created":{"date-parts":[[2017,2,17]],"date-time":"2017-02-17T21:30:16Z","timestamp":1487367016000},"page":"96-106","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["22-azidosalvinorin A exhibits antidepressant-like effect in mice"],"prefix":"10.1016","volume":"800","author":[{"given":"James Oluwagbamigbe","family":"Fajemiroye","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Polepally Reddy","family":"Prabhakar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luiz Carlos da","family":"Cunha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elson Alves","family":"Costa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jordan K.","family":"Zjawiony","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2017.02.031_bib1","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/BF00251121","article-title":"Differential effects of clomipramine given locally or systemically on extracellular 5-hydroxytryptamine in raphe nuclei and frontal cortex. An in vivo microdialysis study","volume":"343","author":"Adell","year":"1991","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"10.1016\/j.ejphar.2017.02.031_bib2","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1002\/syn.890010511","article-title":"Modification of 5-HT neuron properties by sustained administration of the 5-HT1A agonist gepirone: electrophysiological studies in the rat brain","volume":"1","author":"Blier","year":"1987","journal-title":"Synapse"},{"key":"10.1016\/j.ejphar.2017.02.031_bib3","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/0165-6147(94)90315-8","article-title":"Current advances and trends in the treatment of depression","volume":"15","author":"Blier","year":"1994","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejphar.2017.02.031_bib4","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0924-977X(02)00057-3","article-title":"The role of noradrenaline and selective noradrenaline reuptake inhibition in depression","volume":"12","author":"Brunello","year":"2002","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"6","key":"10.1016\/j.ejphar.2017.02.031_bib5","first-page":"190","article-title":"Salvinorin A, a kappa-opioid receptor agonist hallucinogen: pharmacology and potential template for novel pharmacotherapeutic agents in neuropsychiatric disorders","volume":"8","author":"Butelman","year":"2015","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejphar.2017.02.031_bib6","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1124\/jpet.112.193227","article-title":"Behavioral effects and central nervous system levels of the broadly available \u03ba-agonist hallucinogen salvinorin A are affected by P-glycoprotein modulation in vivo","volume":"341","author":"Butelman","year":"2012","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2017.02.031_bib7","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.tins.2012.05.005","article-title":"kappa opioid receptor\/dynorphin system: genetic and pharmacotherapeutic implications for addiction","volume":"35","author":"Butelman","year":"2012","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.ejphar.2017.02.031_bib8","first-page":"3638","article-title":"The mouse forced swim test","volume":"59","author":"Can","year":"2012","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.ejphar.2017.02.031_bib9","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1124\/jpet.105.092304","article-title":"Depressive-like effects of the \u03ba-opioid receptor agonist salvinorin A on behavior and neurochemistry in rats","volume":"316","author":"Carlezon","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2017.02.031_bib10","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.jep.2013.11.032","article-title":"From local to global-fifty years of research on Salvia divinorum","volume":"151","author":"Casselman","year":"2014","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.ejphar.2017.02.031_bib11","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s40263-013-0071-0","article-title":"Serotonin 5-HT1A receptors as targets for agents to treat psychiatric disorders: rationale and current status of research","volume":"27","author":"Celada","year":"2013","journal-title":"CNS Drugs"},{"key":"10.1016\/j.ejphar.2017.02.031_bib12","doi-asserted-by":"crossref","first-page":"180","DOI":"10.4103\/0019-5545.82567","article-title":"Antidepressants: from MAOIs to SSRIs and more","volume":"53","author":"Chaitra","year":"2011","journal-title":"Indian J. Psychiatry"},{"key":"10.1016\/j.ejphar.2017.02.031_bib13","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1124\/jpet.103.059394","article-title":"Salvinorin A, an active component of the hallucinogenic sage salvia divinorum is a highly efficacious kappa-opioid receptor agonist: structural and functional considerations","volume":"308","author":"Chavkin","year":"2004","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2017.02.031_bib14","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1016\/j.bcp.2013.03.010","article-title":"\u03b1\u2081-Adrenoceptor and serotonin 5-HT(1A) receptor affinity of homobivalent 4-aminoquinoline compounds: an investigation of the effect of linker length","volume":"85","author":"Chen","year":"2013","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejphar.2017.02.031_bib15","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.pnpbp.2013.01.014","article-title":"The activation of \u03b11-adrenoceptors is implicated in the antidepressant-like effect of creatine in the tail suspension test","volume":"44","author":"Cunha","year":"2013","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.ejphar.2017.02.031_bib16","first-page":"285","article-title":"On the role of noradrenergic neurotransmission in the action of desipramine and amitriptyline in animal models of depression","volume":"38","author":"Danysz","year":"1986","journal-title":"Pol. J. Pharmacol. Pharmacy"},{"key":"10.1016\/j.ejphar.2017.02.031_bib17","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1177\/2045125314527985","article-title":"Classical hallucinogens as antidepressants? A review of pharmacodynamics and putative clinical roles","volume":"4","author":"David","year":"2014","journal-title":"Ther. Adv. Psychopharmacol."},{"key":"10.1016\/j.ejphar.2017.02.031_bib18","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1345\/aph.1G185","article-title":"Evaluation of herbal dietary supplements marketed on the internet for recreational use","volume":"39","author":"Dennehy","year":"2005","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.ejphar.2017.02.031_bib19","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1124\/jpet.106.118935","article-title":"Differential effects of the tricyclic antidepressant desipramine on the density of adrenergic receptors in juvenile and adult rats","volume":"321","author":"Deupree","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2017.02.031_bib20","doi-asserted-by":"crossref","first-page":"34470","DOI":"10.1074\/jbc.M113.515668","article-title":"The chemotype-selective modes of action of \u03ba-opioid receptor agonists","volume":"288","author":"Eyal","year":"2013","journal-title":"JBC"},{"key":"10.1016\/j.ejphar.2017.02.031_bib21","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1177\/0269881114536789","article-title":"Plurality of anxiety and depression alteration mechanism by oleanolic acid","volume":"10","author":"Fajemiroye","year":"2014","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.ejphar.2017.02.031_bib22","doi-asserted-by":"crossref","first-page":"11582","DOI":"10.1038\/srep11582","article-title":"Oleanolic acid acrylate elicits antidepressant-like effect mediated by 5-HT1A receptor","volume":"5","author":"Fajemiroye","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2017.02.031_bib23","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/fcp.12186","article-title":"Treatment of anxiety and depression: medicinal plants in retrospect","volume":"30","author":"Fajemiroye","year":"2016","journal-title":"Fundam. Clin. Pharmacol."},{"key":"10.1016\/j.ejphar.2017.02.031_bib24","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1210\/edrv-17-2-187","article-title":"Antidepressants and hypothalamic\u2013pituitary\u2013adrenocortical regulation","volume":"17","author":"Holsboer","year":"1996","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.ejphar.2017.02.031_bib25","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.neuroimage.2008.03.003","article-title":"Pharmacokinetics of the potent hallucinogen, salvinorin A in primates parallels the rapid onset and short duration of effects in humans","volume":"41","author":"Hooker","year":"2008","journal-title":"Neuroimage"},{"key":"10.1016\/j.ejphar.2017.02.031_bib26","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1126\/science.136.3511.123","article-title":"Drug screening and evaluative procedures","volume":"136","author":"Irwin","year":"1962","journal-title":"Science"},{"key":"10.1016\/j.ejphar.2017.02.031_bib27","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/BF00401402","article-title":"Comprehensive observational assessment: Ia. A systematic, quantitative procedure for assessing the behavioral and physiologic state of the mouse","volume":"13","author":"Irwin","year":"1968","journal-title":"Psychopharmacologia"},{"key":"10.1016\/j.ejphar.2017.02.031_bib28","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.drugalcdep.2010.11.005","article-title":"Human psychopharmacology and dose-effects of salvinorin A, a \u03ba-opioid agonist hallucinogen present in the plant Salvia divinorum","volume":"115","author":"Johnson","year":"2011","journal-title":"Drug Alcohol. Depend."},{"key":"10.1016\/j.ejphar.2017.02.031_bib29","doi-asserted-by":"crossref","first-page":"5791","DOI":"10.2174\/138161212803523581","article-title":"Neurobiology of depression and novel antidepressant drug targets","volume":"18","author":"Kern","year":"2012","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.ejphar.2017.02.031_bib30","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/0028-3908(83)90024-2","article-title":"Involvement of alpha- and beta 1-adrenergic mechanisms in the immobility-reducing action of desipramine in the forced swimming test","volume":"22","author":"Kitada","year":"1983","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2017.02.031_bib31","first-page":"347","article-title":"Antidepressants given repeatedly increase the alpha 1-adrenoceptor agonist affinity in the rat brain","volume":"43","author":"Klimek","year":"1991","journal-title":"Pol. J. Pharmacol. Pharm."},{"key":"10.1016\/j.ejphar.2017.02.031_bib32","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.pnpbp.2009.11.015","article-title":"Antidepressant-like effect of the methanolic extract from Bupleurum falcatum in the tail suspension test","volume":"34","author":"Kwon","year":"2010","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.ejphar.2017.02.031_bib33","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1021\/acschemneuro.5b00092","article-title":"Structure-activity relationship studies of functionally selective kappa opioid receptor agonists that modulate ERK 1\/2 phosphorylation while preserving G protein over \u03b2-arrestin2 signaling bias","volume":"19","author":"Lovell","year":"2015","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ejphar.2017.02.031_bib34","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.tins.2012.11.002","article-title":"Opioid receptors: distinct roles in mood disorders","volume":"36","author":"Lutz","year":"2013","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.ejphar.2017.02.031_bib35","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s00213-012-2912-9","article-title":"Dose-related effects of salvinorin A in humans: dissociative, hallucinogenic, and memory effects","volume":"226","author":"MacLean","year":"2013","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ejphar.2017.02.031_bib36","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1358\/mf.2001.23.1.619175","article-title":"Alpha 2-Adrenoceptor activity induces the antidepressant-like glycolipid in mouse forced swimming","volume":"23","author":"Masuda","year":"2001","journal-title":"Methods Find. Exp. Clin. Pharmacol."},{"key":"10.1016\/j.ejphar.2017.02.031_bib37","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/S0022-3565(24)29479-9","article-title":"Antidepressant-like behavioral effects in 5-hydroxytryptamine1A and 5-hydroxytry-ptamine 1B receptor mutant mice","volume":"298","author":"Mayorga","year":"2001","journal-title":"JPET"},{"key":"10.1016\/j.ejphar.2017.02.031_bib38","first-page":"233","article-title":"A method for the routine assessment of fore- and hindlimb grip strength of rats and mice","volume":"1","author":"Meyer","year":"1979","journal-title":"Neurobehav. Toxicol."},{"key":"10.1016\/j.ejphar.2017.02.031_bib39","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1177\/0192623310385255","article-title":"Functional assays for neurotoxicity testing","volume":"39","author":"Moser","year":"2011","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.ejphar.2017.02.031_bib40","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.pharmthera.2003.11.002","article-title":"Hallucinogens","volume":"101","author":"Nichols","year":"2004","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2017.02.031_bib41","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s00213-004-2048-7","article-title":"Forced swimming test in mice: a review of antidepressant activity","volume":"177","author":"Petit-Demouliere","year":"2005","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ejphar.2017.02.031_bib42","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.ejmech.2014.07.077","article-title":"Michael acceptor approach to the design of new salvinorin A-based high affinity ligands for the kappa-opioid receptor","volume":"85","author":"Polepally","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejphar.2017.02.031_bib43","first-page":"327","article-title":"Behavioral despair in mice: a primary screening test for antidepressants","volume":"229","author":"Porsolt","year":"1977","journal-title":"Arch. Int. Pharmacodyn. Ther."},{"key":"10.1016\/j.ejphar.2017.02.031_bib44","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.biopsych.2012.06.012","article-title":"Dose-related behavioral, subjective, endocrine, and psychophysiological effects of the \u03ba-opioid agonist Salvinorin A in humans","volume":"72","author":"Ranganathan","year":"2012","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.ejphar.2017.02.031_bib45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s002130050638","article-title":"Dose-dependent noradrenergic and serotonergic properties of venlafaxine in animal models indicative of antidepressant activity","volume":"138","author":"Redrobe","year":"1998","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.ejphar.2017.02.031_bib46","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1177\/026988119801200404","article-title":"Psychopharmacological profile of the selective serotonin reuptake inhibitor, paroxetine: implication of noradrenergic and serotonergic mechanisms","volume":"12","author":"Redrobe","year":"1998","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.ejphar.2017.02.031_bib47","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.neuropharm.2013.09.021","article-title":"LY2456302 is a novel, potent, orally-bioavailable small molecule \u03ba-selective antagonist with activity in animal models predictive of efficacy in mood and addictive disorders","volume":"77","author":"Rorick-Kehn","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2017.02.031_bib48","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/00004714-199902000-00013","article-title":"Effects of SSRIs on sexual function: a critical review","volume":"19","author":"Rosen","year":"1999","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.ejphar.2017.02.031_bib49","doi-asserted-by":"crossref","first-page":"11934","DOI":"10.1073\/pnas.182234399","article-title":"Salvinorin A: a potent naturally occurring nonnitrogenous kappa opioid selective agonist","volume":"99","author":"Roth","year":"2002","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.ejphar.2017.02.031_bib50","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.pharmthera.2004.03.004","article-title":"Screening the receptorome to discover the molecular targets for plant-derived psychoactive compounds: a novel approach for CNS drug discovery","volume":"102","author":"Roth","year":"2004","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2017.02.031_bib51","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1097\/00005344-198704000-00016","article-title":"Modulation of norepinephrine release through alpha 1- and alpha 2-adrenoceptors in rat isolated kidney","volume":"9","author":"Rump","year":"1987","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.ejphar.2017.02.031_bib52","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1517\/13543776.15.10.1333","article-title":"\u03b11-adrenoceptors as potential therapeutic targets","volume":"15","author":"Sarma","year":"2005","journal-title":"Expert. Opin. Ther. Pat."},{"key":"10.1016\/j.ejphar.2017.02.031_bib53","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.pneurobio.2009.01.009","article-title":"5-HT(1A) receptor function in major depressive disorder","volume":"88","author":"Savitz","year":"2009","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.ejphar.2017.02.031_bib54","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0378-8741(94)90116-3","article-title":"Salvia divinorum and salvinorin A: new pharmacologic findings","volume":"43","author":"Siebert","year":"1994","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.ejphar.2017.02.031_bib55","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1039\/b902338k","article-title":"High-throughput synthesis of azide libraries suitable for direct \u201cclick\u201d chemistry and in situ screening","volume":"7","author":"Srinivasan","year":"2009","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.ejphar.2017.02.031_bib56","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/BF00428203","article-title":"The tail suspension test: a new method for screening antidepressants in mice","volume":"85","author":"Steru","year":"1985","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ejphar.2017.02.031_bib57","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/S0006-3223(99)00234-6","article-title":"Alpha-1-noradrenergic neurotransmission, corticosterone, and behavioral depression","volume":"46","author":"Stone","year":"1999","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.ejphar.2017.02.031_bib58","doi-asserted-by":"crossref","first-page":"5099","DOI":"10.1016\/j.bmcl.2004.07.081","article-title":"A facile method for the preparation of deuterium labeled salvinorin A: synthesis of [2,2,2-2H3]-salvinorin A","volume":"14","author":"Tidgewell","year":"2004","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejphar.2017.02.031_bib59","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0378-8741(83)90004-1","article-title":"Ethnopharmacology of ska Maria Pastora (Salvia divinorum Epling and Jativa-M.)","volume":"7","author":"Vald\u00e9s","year":"1983","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.ejphar.2017.02.031_bib60","doi-asserted-by":"crossref","first-page":"3935","DOI":"10.1021\/ol016820d","article-title":"Salvinorin C, a new neoclerodane diterpene from a bioactive fraction of the hallucinogenic Mexican mint Salvia divinorum","volume":"3","author":"Vald\u00e9s","year":"2001","journal-title":"Org. Lett."},{"key":"10.1016\/j.ejphar.2017.02.031_bib61","doi-asserted-by":"crossref","unstructured":"Wasson, R. G., 1962. A New Mexican Psychotropic Drug from the Mint Family. Botanical Museum Leaflets, Harvard University 20, pp. 77\u201384.","DOI":"10.5962\/p.168538"},{"key":"10.1016\/j.ejphar.2017.02.031_bib62","doi-asserted-by":"crossref","unstructured":"Wasson, R. G., 1963. Notes on the Present Status of Ololuiqui and the Other Hallucinogens of Mexico. Botanical Museum Leaflets, Harvard University 20, pp.161\u2013193.","DOI":"10.5962\/p.168541"},{"key":"10.1016\/j.ejphar.2017.02.031_bib63","doi-asserted-by":"crossref","first-page":"137","DOI":"10.2174\/0929867305666220314202430","article-title":"Structural aspects of monoamine oxidase and its reversible inhibition","volume":"5","author":"Wouters","year":"1998","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejphar.2017.02.031_bib64","doi-asserted-by":"crossref","first-page":"4433","DOI":"10.1038\/srep04433","article-title":"Antidepressant-like effects of auraptenol in mice","volume":"4","author":"Xiaosu","year":"2014","journal-title":"Sci. Rep."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299917300973?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299917300973?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,15]],"date-time":"2025-06-15T13:32:26Z","timestamp":1749994346000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299917300973"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":64,"alternative-id":["S0014299917300973"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2017.02.031","relation":{},"ISSN":["0014-2999"],"issn-type":[{"type":"print","value":"0014-2999"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"22-azidosalvinorin A exhibits antidepressant-like effect in mice","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2017.02.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}